The role of FOLFIRINOX in metastatic pancreatic cancer: A meta-analysis

B Zhang, F Zhou, J Hong, DM Ng, T Yang… - World Journal of …, 2021 - Springer
Background The prognosis of pancreatic cancer (PC) is extremely poor, and most patients
with metastatic PC still receive palliative care. Here, we report the efficacy and safety of …

Molecular features and clinical management of hereditary pancreatic cancer syndromes and familial pancreatic cancer

A Kasuga, T Okamoto, S Udagawa, C Mori… - International Journal of …, 2022 - mdpi.com
Hereditary pancreatic cancers are caused by several inherited genes. Familial pancreatic
cancer is defined as pancreatic cancer arising in a patient with at least two first-degree …

Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis

Z Zhu, X Wang, W Zhang, M Gong, S Zhang… - Frontiers in …, 2022 - frontiersin.org
Purpose The anti-tumour effect of Huaier has been demonstrated in a variety of tumours.
Ferroptosis is a newly identified type of programmed cell death accompanied by the …

Proton pump inhibitors use and the risk of pancreatic cancer: evidence from eleven epidemiological studies, comprising 1.5 million individuals

TN Poly, MM Islam, BA Walther, MC Lin, YC Li - Cancers, 2022 - mdpi.com
Simple Summary Proton pump inhibitors are commonly prescribed medications for
gastrointestinal disorders, which bring gastric acid down to normal levels. However, the …

Adherence to NCCN genetic testing guidelines in pancreatic cancer and impact on treatment

F Crowley, S Gandhi, M Rudshteyn, M Sehmbhi… - The …, 2023 - academic.oup.com
Abstract Introduction National Comprehensive Cancer Network (NCCN) 2019 Guidelines
recommend universal germline (GL) testing for patients (pts) with pancreatic cancer (PC) …

Metabolic syndrome and risk of pancreatic cancer: a population‐based prospective cohort study

B Xia, Q He, Y Pan, F Gao, A Liu, Y Tang… - … journal of cancer, 2020 - Wiley Online Library
Metabolic syndrome (MetS) and its components may link to pancreatic cancer risk; however,
current epidemiological evidence is limited, and the potential mechanisms underlying the …

Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990–2017

A Aryannejad, M Tabary, N Ebrahimi, E Mohammadi… - Pancreatology, 2021 - Elsevier
Background Pancreatic cancer (PC) is among the most lethal cancers worldwide, and the
quality of care provided to PC patients is a vital public health concern. We aimed to …

Combination immunotherapy using oncolytic virus for the treatment of advanced solid tumors

CM Oh, HJ Chon, C Kim - International journal of molecular sciences, 2020 - mdpi.com
Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …

Exercise medicine in the management of pancreatic cancer: a systematic review

H Luo, DA Galvão, RU Newton, P Lopez, C Tang… - Pancreas, 2021 - journals.lww.com
The aim of this study was to examine the health-related effects of exercise in patients with
pancreatic cancer (PanCa) through a systematic review of current evidence. Studies were …

[HTML][HTML] Early prediction of pancreatic cancer from new-onset diabetes: An associazione Italiana oncologia medica (AIOM)/associazione medici diabetologi (AMD) …

M Gallo, V Adinolfi, L Morviducci, S Acquati, E Tuveri… - ESMO open, 2021 - Elsevier
Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in
detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic …